KEN TAKANASHI

CIK 1657768 · last filed 2026-03-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.53M

Companies

2

Total Filings

19

Lifetime Open-Market Net

$27.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WVE Director 9,630,351 $5.87 $56.53M $3.96M 13 2026-03-26
Satsuma Pharmaceuticals, Inc. (STSA) Delisted Director 24,847,694 $1.10 $27.33M $23.57M 6 2023-06-08

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-12-07 Satsuma Pharmaceuticals, Inc. (STSA) Delisted Grant (A) $0 EDGAR
2020-08-20 WVE Grant (A) $0 EDGAR
2020-06-16 Satsuma Pharmaceuticals, Inc. (STSA) Delisted Grant (A) $0 EDGAR
2019-09-17 Satsuma Pharmaceuticals, Inc. (STSA) Delisted Mixed +574,184 $3.50M EDGAR
2019-08-16 WVE Grant (A) $0 EDGAR
2018-08-15 WVE Grant (A) $0 EDGAR
2017-08-17 WVE Grant (A) $0 EDGAR
2016-11-14 WVE Grant (A) $0 EDGAR
2015-11-18 WVE Mixed +573,326 $4.00M EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.